Evidence map›Paper›PMID 37070350›Full record

SynthesisRenal failure2023

Incidence and risk factors for recurrent focal segmental glomerulosclerosis after kidney transplantation: a meta-analysis.

Jiang Bai, Tianxiang Zhang, Yan Wang, Jiajing Cao, Zihui Duan, Linghui Ji, Yun Zhou, Chuan Hao, Qiang Guo

Open access · goldAbstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Renal failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Post-Transplant Glomerulonephritis: Challenges and Solutions.International journal of nephrology and renovascular disease · 2024
    Review
  10. Transplant Trial Watch.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jiang BaiSecond Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China.
Tianxiang ZhangDepartment of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yan WangShanxi Medical University, Taiyuan, Shanxi, China.
Jiajing CaoShanxi Medical University, Taiyuan, Shanxi, China.
Zihui DuanShanxi Medical University, Taiyuan, Shanxi, China.
Linghui JiShanxi Medical University, Taiyuan, Shanxi, China.
Yun ZhouDepartment of Nephrology, Shanxi Provincial People's Hospital (Fifth Hospital) of Shanxi Medical University, Taiyuan, Shanxi, China.
Chuan HaoDepartment of Urology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Qiang GuoDepartment of Urology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Shanxi Medical University · CNSecond Hospital of Shanxi Medical University · CNRenji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo systematically review the incidence and risk factors for recurrent FSGS after kidney transplantation.

methodsWe searched PubMed, Embase, Medline, Web of Science, the Cochrane Library, CNKI, CBMdisc, Wanfang, and Weipu for case-control studies related to recurrent FSGS from the establishment until October 2022. The protocol was registered on PROSPERO (CRD42022315448). Data were analyzed using Stata 12.0, with odds ratios (counting data) and standardized mean difference (continuous data) being considered as effect sizes. If the

resultsA total of 22 studies with 966 patients and 12 factors were included in the meta-analysis. There were 358 patients with recurrent FSGS and 608 patients without FSGS after kidney transplantation. The results showed that the recurrence rate of FSGS after kidney transplantation was 38% (95% CI: 31%-44%). Age at transplantation (SMD = -0.47, 95% CI -0.73 to -0.20,

conclusionsThe recurrence of FSGS after kidney transplantation remains high. Clinical decision-making should warrant further consideration of these factors, including age, original disease progression, proteinuria, related donor, and nephrectomy of native kidneys.

Indexed as

Glomerulosclerosis, Focal SegmentalKidney TransplantationHumansIncidenceLiving DonorsProteinuriaRecurrenceRisk Factorsfocal segmental glomerulosclerosisincidencekidney transplantationMeta-analysisrisk factors

Identifiers

PMID37070350
PMCPMC10120546
OpenAlexW4366237416

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.